dc.creatorCartier Rovirosa, Luis
dc.creatorCastilio,
dc.creatorCea,
dc.creatorVillagra,
dc.date.accessioned2019-01-29T15:32:05Z
dc.date.available2019-01-29T15:32:05Z
dc.date.created2019-01-29T15:32:05Z
dc.date.issued1995
dc.identifierJournal of Neurology Neurosurgery and Psychiatry, Volumen 58, Issue 2, 2018, Pages 244-246
dc.identifier00223050
dc.identifier10.1136/jnnp.58.2.244
dc.identifierhttps://repositorio.uchile.cl/handle/2250/161557
dc.description.abstractA prospective study was carried out on 48 patients with HTLV I associated myelopathy/tropical spastic paraparesis (HAM/TSP) to assess the association between this entity and Sjogren's syndrome. Fourteen patients (29.1%) had chronic dacryosialadenitis confirmed by a positive Schirmer's test and salivary gland biopsy. None of these patients had evidence of collagen disease and tests for Ro, La, and rheumatoid factor were negative except in one case. Therefore, the dacryosialadenitis could not be classified as either primary or secondary Sjogren's syndrome. Ten of the 14 patients (71.4%) had other systems (haematological, articular, dermatological, or respiratory) involved apart from the neurological and exocrine gland pathology. The findings suggest that the dacryosialadenitis associated with HTLV I is a disease of viral origin distinct from Sjogren's syndrome.
dc.languageen
dc.publisherBMJ Publishing Group
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceJournal of Neurology Neurosurgery and Psychiatry
dc.subjectDacryosialadenitis
dc.subjectHTLV I associated myelopathy
dc.subjectSjogren's syndrome
dc.titleChronic dacryosialadenitis in HTLV I associated myelopathy
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución